South Korea Cardiovascular Devices Market Size, Share and Forecast Trends - Growth Analysis and Outlook Report 2026-2030

South Korea's cardiovascular devices market encompasses products used to diagnose, monitor, and treat heart and blood vessel conditions, including stents, catheters, heart valves, cardiac rhythm management devices, and electrophysiology equipment. The market sits within a total South Korean medical devices sector valued at approximately $7.57 billion in 2025, reflecting cardiovascular devices as a major specialty category. Regulated by the Ministry of Food and Drug Safety and supported by the National Health Insurance Service, the market benefits from a well-structured reimbursement framework that ensures broad patient access to advanced cardiac technologies.

• •Estimated market value of $1.57 billion in 2025, with projected CAGR of 7.13%
• •Represents a substantial portion of South Korea's $7.57 billion medical devices market
• •Governed by MFDS and supported by NHIS reimbursement policies

The primary catalyst for market expansion is South Korea's demographic shift into a super-aged society in 2025, with more than 20.6% of the population now over the age of 65, directly increasing the burden of cardiorespiratory diseases. Rising prevalence of hypertension, coronary artery disease, and heart failure among the elderly population is driving greater demand for interventional and diagnostic cardiovascular procedures. Additionally, the country's advanced healthcare infrastructure and high healthcare expenditure per capita enable rapid adoption of innovative medical technologies, while government initiatives to localize medical device manufacturing strengthen the domestic supply chain.

• •Over 20.6% of population aged 65+ in 2025, accelerating cardiovascular disease burden
• •Strong healthcare infrastructure and universal coverage supporting device adoption
• •Government push for domestic medical device manufacturing reducing import dependence

The cardiovascular devices market in South Korea is segmented into device types including cardiac rhythm management devices, interventional cardiology products, electrophysiology equipment, and vascular devices. Interventional cardiology, particularly coronary stents and catheters, constitutes a significant share given the high incidence of coronary artery disease. Seoul and surrounding metropolitan regions dominate market activity due to concentration of major hospitals and tertiary care centers, though regional medical hubs in Busan and Daegu are expanding access. South Korea's positioning within the broader Asia-Pacific medical devices market, which includes economies like Japan, China, and India, allows for both intra-regional trade and technology exchange.

• •Interventional cardiology leads the segment, with stents and catheters as high-volume categories
• •Seoul metropolitan area accounts for majority of procedures and device consumption
• •Part of Asia-Pacific market, benefiting from regional medical device trade and partnerships

What are the recent trends and outlook?

Key trends shaping the market include the shift toward minimally invasive surgical procedures, adoption of bioresorbable stents, and integration of artificial intelligence in cardiac diagnostics and imaging. The market is expected to sustain a growth trajectory supported by the aging population, expanding indications for device-based therapies, and continued healthcare infrastructure investment. Over the forecast period, the move toward personalized medicine and next-generation implantable devices presents opportunities for both established manufacturers and emerging local innovators.

• •Minimally invasive procedures and bioresorbable stent technologies gaining traction
• •AI-enabled cardiac diagnostics and remote monitoring devices emerging as high-growth sub-segments
• •Market projected to reach approximately $2.88 billion by 2035 on current trajectory